MK-801 free base · Synonyms: Dizocilpine
Dizocilpine, a potent anticonvulsant, is a selective and non-competitive NMDA receptor antagonist.
For research use only. Not for human or veterinary use.
MK-801 structure
CAS No.: 77086-21-6
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 250 mg | USD 440.00 | BP-02085-250mg | In stock | Get quote |
| 500 mg | USD 730.00 | BP-02085-500mg | In stock | Get quote |
| 1 g | USD 1,170.00 | BP-02085-1g | In stock | Get quote |
| 2 g | USD 1,875.00 | BP-02085-2g | In stock | Get quote |
| 3 g | USD 2,250.00 | BP-02085-3g | In stock | Get quote |
| 5 g | USD 3,000.00 | BP-02085-5g | In stock | Get quote |
| 10 g | USD 4,800.00 | BP-02085-10g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
Dizocilpine (MK-801), a potent anticonvulsant, is a selective and non-competitive NMDA receptor antagonist, with a Kd of 37.2 nM in rat brain membranes. Dizocilpine acts by binding to a site located within the NMDA associated ion channel and thus prevents Ca2+ flux.
Biological activity
In Vitro Dizocilpine (MK-801) progressively suppresses of current induced by NMDA. Mg2+ (10 mM) prevents Dizocilpine from blocking the N-Me-D-Asp-induced current, even when Dizocilpine is applied for a long time in the presence of NMDA. Dizocilpine blocks NMDA-activated single-channel activity in outside-out patches. Dizocilpine (MK-801; <500 μM) inhibits activation of microglia induced by LPS with increased Cox-2 protein expression in BV-2 cells. Dizocilpine (<500 μM) reduces microglial TNF-α output with an EC50 of 400 μM in BV-2 cells.
Identifiers
- SMILES
-
C[C@]12N[C@H](CC3=CC=CC=C13)C1=CC=CC=C21 - InChIKey
-
LBOJYSIDWZQNJS-CVEARBPZSA-N
Specifications
- MW (average)
- 221.2970
- Formula
- C16H15N
- CAS No.
- 77086-21-6
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
Same target
Search iGluRSame research area
Search Neurological Disease- BP-00013 THK5351 free base · >98%
- BP-00047 TAK-071 free base · >98%
- BP-00101 Oditrasertib free base · >98%
- BP-00937 ML193 free base · >98%
- BP-01018 Taminadenant free base · >98%
- BP-01213 ML218 free base · >98%
- BP-01638 Nitecapone free base · >98%
- BP-01702A Quetiapine sulfoxide dihydrochloride salt · >98%